Combination therapy: A feasibility strategy for CAR-T cell therapy in the treatment of solid tumors

Chimeric antigen receptor (CAR) T-cell therapies have been demonstrated to have durable and potentially curative therapeutic efficacies in patients with hematological malignancies. Currently, multiple clinical trials in CAR-T cell therapy have been evaluated for the treatment of patients with solid...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jinjing, Wang, Yali, Shi, Jing, Liu, Juan, Li, Qingguo, Chen, Longzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036511/
https://www.ncbi.nlm.nih.gov/pubmed/30008901
http://dx.doi.org/10.3892/ol.2018.8946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036511/
https://www.ncbi.nlm.nih.gov/pubmed/30008901
http://dx.doi.org/10.3892/ol.2018.8946

Ejemplares similares